Seeking Alpha

Japanese #3 drugmaker Daiichi Sankyo is buying majority control of India's #1 pharma firm...

Japanese #3 drugmaker Daiichi Sankyo is buying majority control of India's #1 pharma firm Ranbaxy for up to $4.6B, a 31.4% premium. Keep an eye on Dr. Reddy's (RDY).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)